HJ

Hitesh Jyotiram Rathod

Active Director Designated Partner DIN 11382737
DIN 11382737 First appointment Nov 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Hitesh Jyotiram Rathod

Data last updated:

Hitesh Jyotiram Rathod is a Designated Partner at Vakratoondaa Medicare Multispecility Hospital Llp (since 2025).

DIN 11382737
Primary Designation Designated Partner
First Appointment 14 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner14 Nov 20252025Active

Board colleagues of Hitesh Jyotiram Rathod

Directorship timeline

Open interactive timeline →
Vakratoondaa Medicare Multispecility Hospital Llp
Premium access

Shareholding and investment profile for Hitesh Jyotiram Rathod

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hitesh Jyotiram Rathod

Hitesh Jyotiram Rathod currently holds 1 directorship: Vakratoondaa Medicare Multispecility Hospital Llp (Designated Partner, since 14 Nov 2025).

Hitesh Jyotiram Rathod was first appointed on 14 Nov 2025 as Designated Partner at Vakratoondaa Medicare Multispecility Hospital Llp.

The current boards of Hitesh Jyotiram Rathod's companies include Abhilasha Dhirendra Sinha (Vakratoondaa Medicare Multispecility Hospital Llp), Arun Vijayshankar Tiwari (Vakratoondaa Medicare Multispecility Hospital Llp), Swati Lalit Sonawane (Vakratoondaa Medicare Multispecility Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available